GridAI Technologies GRDX
NASDAQ GRDX
$2.95 -0.07 (-2.16%)
As of: Sep 10, 2026 · 3:09 PM EDT

GridAI Technologies (GRDX) Current Leases (2020 - 2026)

GridAI Technologies' (GRDX) quarterly Current Leases came in at $135609.0 in Q2 2026, little changed on a YoY basis from $135609.0 in Q2 2025, and little changed quarter-over-quarter from $135609.0 in Q4 2025.

Analysis

GridAI Technologies (GRDX) Current Leases (2020 - 2026) Analysis & Trends

GridAI Technologies (GRDX) has reported Current Leases for 7 consecutive years, with $135609.0 the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Current Leases changed 0.0% year-over-year to $135609.0; the trailing twelve-month figure through Jun 2026 stood at $135609.0 (changed 0.0% YoY), and the FY2025 full-year result was $135609.0, up 66.37% from the prior year.
  • Current Leases held at $135609.0 in Q2 2026 per GRDX's latest filing, from $135609.0 in the prior quarter.
  • Across five years, Current Leases topped out at $135609.0 in Q1 2025 and bottomed at $62673.0 in Q2 2022.
  • Historically, Current Leases has averaged $90300.7 across 5 years, with a median of $74324.0 in 2024.
  • The sharpest annual moves came in 2022 and 2025: Current Leases sank 32.07% in 2022, then jumped 90.42% in 2025.
  • Over 5 years, Current Leases stood at $66151.0 in 2022, then advanced by 1.45% to $67111.0 in 2023, then grew by 21.46% to $81510.0 in 2024, then soared by 66.37% to $135609.0 in 2025, then changed by 0.0% to $135609.0 in 2026.
  • According to Business Quant data, Current Leases over the past three periods registered $135609.0, $135609.0, and $135609.0 for Q2 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Leases (Qtr)
1 Amgen 206.74 Bn 192.75 Bn 7.24 Bn -
2 Gilead Sciences 179.96 Bn 176.78 Bn 6.22 Bn -
3 Vertex Pharmaceuticals 131.20 Bn 123.35 Bn 2.84 Bn -
4 Regeneron Pharmaceuticals 82.05 Bn 74.05 Bn 3.93 Bn 720.00 Mn
5 Argenx Se 60.28 Bn 55.10 Bn 1.37 Bn 11.00 Mn
6 Moderna 53.67 Bn 48.54 Bn 52.00 Mn -
7 Alnylam Pharmaceuticals 33.08 Bn 29.78 Bn 992.69 Mn 45.93 Mn
8 Biogen 31.91 Bn 30.62 Bn 1.96 Bn -
9 Roivant Sciences 29.22 Bn 29.22 Bn 1.16 Mn 12.38 Mn
10 GridAI Technologies 18.97 Mn 18.97 Mn -36,514.00 135,609.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 135,609.00
Dec 31, 2025 135,609.00
Sep 30, 2025 135,609.00
Jun 30, 2025 135,609.00
Mar 31, 2025 135,609.00
Dec 31, 2024 81,510.00
Sep 30, 2024 79,454.00
Jun 30, 2024 77,432.00
Mar 31, 2024 71,216.00
Dec 31, 2023 67,111.00
Sep 30, 2023 65,322.00
Jun 30, 2023 63,564.00
Mar 31, 2023 67,936.00
Dec 31, 2022 66,151.00
Sep 30, 2022 64,397.00
Jun 30, 2022 62,673.00
Dec 31, 2021 77,989.00
Sep 30, 2021 94,794.00
Mar 31, 2021 56,702.00
Dec 31, 2020 57,417.00